All Articles

A Chinese AI innovator and a new European biotech just sealed a massive deal. It’s a blueprint for the future of medicine, where technology and strategy unite for patients.

A new AI platform, born from its founder's own cancer battle, aims to give patients the tools to navigate complex treatments and advocate for their own care.

A single drug receptor could treat cancer, psoriasis, and liver disease. Can-Fite’s new scientific validation boosts its platform, but clinical and financial hurdles loom.

Polaris appoints Sealed Air CEO Dustin Semach to its board, a move signaling a calculated pivot towards technology and financial rigor in its powersports strategy.

With new funding from top VCs, DropGenie is shrinking gene editing to power the next wave of AI-driven drug discovery using precious patient cells.

XTEL's new SAP Store integration dissolves the trade-off between deep ERP integration and best-in-class tools, deploying agentic AI to reshape CPG profitability.

MapLight's Phase 2 trial for ASD missed its primary goal, but a powerful signal in reducing irritability in teens could reshape its future and offer a safer alternative.

A new prostate cancer drug is emerging from a powerful alliance. We deconstruct the strategic rationale behind the deal, revealing a model for the future.

Brunswick Corp. promises 'multi-million-dollar savings' from operational shifts at its Lowell plant. But behind the corporate buzzwords, a community weighs the price of efficiency.

As travelers trade mega-resorts for meaningful moments, Azamara Cruises bets its future on a simple idea: the next big thing is small. Here's the strategy.

New high-grade gold discoveries at Island Gold aren't just a lucky find; they're the core of a strategy to fuel a major mill expansion and lower costs.

The global firm nearly doubled its access to the UK's key public works framework, securing pivotal roles in nuclear energy and climate resilience projects.

Merck's positive Phase 3 results for tulisokibart signal a new era for UC care, targeting both fibrosis and inflammation in a potential first-in-class win.

Infrastructure services giant ITG launches its IPO, aiming to repay debt and fund growth amid surging demand for broadband, 5G, and AI-ready data centers.

How one artist leveraged entrepreneurial success, from Amazon logistics to a hit musical, to self-fund a mission and rewrite the playbook on social impact.

A 21% resource boost at its Esperanza project positions Zacatecas Silver with high-grade, near-surface gold, hinting at a low-capex future.

Amid market volatility, Canyon Partners' latest €400M CLO showcases strategic precision. We deconstruct the deal and what it signals for European credit.

As small businesses face relentless threats, a new unified approach is gaining ground. Guardz's recent award signals a pivotal shift from fragmented tools to AI-driven, identity-centric platforms.

State Grid's local efforts in Lintao County reveal a sophisticated operational model where power supply becomes a tool for national agricultural strategy.

A landmark partnership in Oklahoma brings Direct Primary Care to ACA plans, using tech to restore the human connection at the heart of medicine. Is this the future?